A recently published study by Future Market Insights, the global pleural disease therapeutics market is expected to accumulate a valuation of US$ 9.4 billion by 2033, registering a CAGR of 6.5% across the forthcoming decade. Increasing prevalence of congestive heart failure, and other heart conditions, lung conditions, pneumonia, cancer and tuberculosis is estimated to propel …
Author Archives: Editor AN
Global Optic Atrophy Management Market to surpass US$ 15 billion by 2033, growing at a 4.9% CAGR: FMI Study
According to Future Market Insights, the optic atrophy management market is slated to experience a CAGR of 4.9% from 2023 to 2033, anticipated to reach a valuation of US$ 15.63 billion. An existing medical study in gene replacement therapy found a satisfactory safety record but poor medicinal result durability. The findings of the study are …
Medical Disposables Market to be worth US$ 326 Billion by 2033, Reveals Future Market Insights
The Medical Disposables Market revenues were estimated at US$ 153.5 Billion in 2022 and is anticipated to grow at a CAGR of 7.1% from 2023-2033, according to a recently published Future Market Insights report. By the end of 2033, the market is expected to reach US$ 326 Billion. Bandages and Wound Dressings commanded the largest …
Next Generation Immunotherapies Market to reach US$ 268.84 billion by 2033, Monoclonal Antibodies were Primary Drug Class: FMI Report
The global next generation immunotherapies market is estimated to exceed a spectacular valuation of US$ 268.84 billion in 2033, with a compound annual growth rate (CAGR) of 7.5% projected from 2023 to 2033. The vast majority of present immunotherapies, such as checkpoint inhibitors, seek to enhance the immune system’s adaptive response, precisely cytotoxic T cells, …
Global Monkeypox Treatment Market to reach US$ 249 million by 2033, Tecovirimat to account for 61% of all Therapeutic Approaches: FMI
A recent Future Market Insights report on the monkeypox treatment market forecasts that demand is expected to rise at a CAGR of 10.25% from 2023 to 2033. As per the findings, a valuation of US$ 249 million is expected for the market by the end of the said forecast period. Rising products approvals in treatment …
Global Opioid Use Disorder Treatment Market to reach US$ 8.4 billion by 2033, Buprenorphine to account for 81.4% of all Treatments: FMI Study
The global opioid use disorder treatment market size is expected to attain an impressive valuation of US$ 3.07 billion in 2023 and is projected to reach US$ 8.4 billion by 2033, expanding at a CAGR of 10.5% during the forecast period. The drug abuse treatment providers and manufacturers primarily focus on creating awareness among people …
Nasal Polyposis Treatment Market to reach US$ 8.8 billion by 2033, Corticosteroids to Constitute 55% of all Treatments: FMI Report
in value terms by 2023-end and is projected to rise at a CAGR of 6.7% until 2033, according to a recently published report by Future Market Insights. By the end of the said forecast period, a valuation of US$ 8.8 billion is expected for the market. A growing geriatric population suffering from chronic rhinosinusitis, with …
Nutraceuticals Market Geodemographic Study with Consumer Data with Mid-Level Participant by 2032
The global nutraceuticals market is set to witness growth at a CAGR of 12.9% between 2022 and 2032, reaching to an evaluation of USD 1,354.2 Bn by 2032, while it is valued at US$ 402.5 Bn in 2022. Nutraceuticals market survey explains that functional quality can be described as any food product that has an added functionality as a result of the …
Stearic Acid Market Demand & Supply, Consumer Insights with Report in Likely Scenario by 2032
The analysts at FMI followed a multidisciplinary approach during the pandemic to study the growth and development of the Stearic Acid Market. The report features insights on the current growth dynamics and the major revenue reforms prevailing in the market as of 2022 along with the key takeaways over the forecast period 2022 to 2032. The team …
Glandular Ingredients Market Examine on Demand, Study on the Basis of Key Players, Form, Source, Type & End user by 2032
The market for glandular ingredients is projected to be US$ 105.83 billion in 2022 and to increase at a CAGR of 6.9% to US$ 206.25 billion from 2022 to 2032. Dietary supplements with glandular components include nutrient sources that support the operation of particular glands. Ingredients obtained from glands of animals are processed using lyophilization. …